Cresco Labs (CRLBF) EBITDA Margin (2020 - 2026)
Cresco Labs (CRLBF) posted EBITDA Margin of 7.38% for Q1 2026, up 115.79% on a QoQ basis from 46.76% in Q4 2025, and down 81.0% year-over-year from 38.86% in Q1 2025.
Cresco Labs (CRLBF) EBITDA Margin (2020 - 2026) Analysis & Trends
Cresco Labs' EBITDA Margin history runs 7 years deep, the most recent figure standing at 7.38% for Q1 2026.
- Quarterly EBITDA Margin fell 81.0% year-over-year to 7.38% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 4.74% (down 1773.0% YoY) and the FY2025 annual result came in at 4.27%, down 1908.0% from the prior year.
- EBITDA Margin was 7.38% for Q1 2026 at Cresco Labs, up from 46.76% in the prior quarter.
- Across five years, EBITDA Margin topped out at 23.67% in Q1 2022 and bottomed at 56.55% in Q3 2023.
- A 5-year average of 4.24% and a median of 10.81% in 2025 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2023 — EBITDA Margin sank 7638 bps — and 2024, when it surged 7120 bps.
- Cresco Labs' EBITDA Margin stood at 15.3% in 2022, then dropped by 6 bps to 14.4% in 2023, then decreased by 23 bps to 11.03% in 2024, then slumped by 524 bps to 46.76% in 2025, then soared by 116 bps to 7.38% in 2026.
- Business Quant data shows CRLBF's EBITDA Margin at 7.38% in Q1 2026, 46.76% in Q4 2025, and 10.81% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.37% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 36.83% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -38.02% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 41.69% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -2.27% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.74% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.23% |
| 10 | Cresco Labs | 254.96 Mn | 99.57 Mn | 75.45 Mn | 7.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.38% |
| Dec 31, 2025 | -46.76% |
| Sep 30, 2025 | 10.81% |
| Jun 30, 2025 | 9.86% |
| Mar 31, 2025 | 8.20% |
| Dec 31, 2024 | 11.03% |
| Sep 30, 2024 | 14.65% |
| Jun 30, 2024 | 17.56% |
| Mar 31, 2024 | 15.82% |
| Dec 31, 2023 | 14.40% |
| Sep 30, 2023 | -56.55% |
| Jun 30, 2023 | -5.43% |
| Mar 31, 2023 | 1.85% |
| Dec 31, 2022 | 15.30% |
| Sep 30, 2022 | 19.83% |
| Jun 30, 2022 | 10.39% |
| Mar 31, 2022 | 23.67% |
| Dec 31, 2021 | 26.17% |
| Sep 30, 2021 | 32.98% |
| Jun 30, 2021 | 21.68% |